Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Checkpoint kinase 1 (Chk1) is a key regulator of checkpoint signaling in both the unperturbed cell cycle and DNA damage response. Under these conditions, Chk1 becomes active to prevent premature CDK1 activation and mitotic entry until DNA is properly replicated or repaired. It is unclear how Chk1 activity is controlled in the unperturbed cell cycle. During DNA damage, Chk1 is activated by ataxia telangiectasia and Rad3 related (ATR)-mediated phosphorylation; however, it is not entirely clear how this phosphorylation results in Chk1 activation. Here we report an N-terminally truncated alternative splice variant of Chk1, Chk1-S. Importantly, we show that Chk1-S is an endogenous repressor and regulator of Chk1. In the unperturbed cell cycle, Chk1-S interacts with and antagonizes Chk1 to promote the S-to-G2/M phase transition. During DNA damage, Chk1 is phosphorylated, which disrupts the Chk1–Chk1-S interaction, resulting in free, active Chk1 to arrest the cell cycle and facilitate DNA repair. Higher levels of Chk1-S are expressed, along with Chk1, in fetal and cancer tissues than in normal tissues. However, forced overexpression of Chk1-S in cultured cells and tumor xenografts induces premature mitotic entry, mitotic catastrophe, and reduction of tumor growth. The identification of Chk1-S as a unique splice variant and key regulator of Chk1 provides insights into cell cycle regulation and DNA damage response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · cited 13×
“Similarly, Chk1 dissociated from Chk1-S during cisplatin-induced DDR, and the dissociation was prevented by dn-ATR (SI Appendix, Fig.”
BackgroundInfluentialPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320 · cited 2×
“As reported previously (5), both normal and malignant testicular tissues had high levels of Chk1 expression.”
BackgroundATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · cited 12×
“Similarly, Chk1 dissociated from Chk1-S during cisplatin-induced DDR, and the dissociation was prevented by dn-ATR (SI Appendix, Fig.”
BackgroundInfluentialRapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance
Brown, E. J., & Baltimore, D. (2003) · Genes & Development · doi:10.1101/gad.1067403 · Cited by 511
Guo, Z., Kumagai, A., Wang, S. X., & Dunphy, W. G. (2000) · Genes & Development · doi:10.1101/gad.842500 · Cited by 417
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
Self-citationChk1 promotes replication fork progression by controlling replication initiation
Petermann, E., Woodcock, M., & Helleday, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005031107 · Cited by 308
Cole, K. A., Huggins, J., Laquaglia, M., Hulderman, C. E., Russell, M. R., Bosse, K., Diskin, S. J., Attiyeh, E. F., Sennett, R., Norris, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012351108 · Cited by 249
hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis
Pabla, N., Ma, Z., McIlhatton, M. A., Fishel, R., & Dong, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210989 · Cited by 107 · cited 1×
“Results and Discussion During our study of DNA damage signaling (32, 33), we observed two prominent bands in Chk1 immunoblots: the Chk1 band at 56 kDa and a faster-migrating band of 43 kDa.”
BackgroundSelf-citation
Research works printed but not linked: 30
- P Nurse, A long twentieth century of the cell cycle and beyond. Cell 100, 71–78 (2000). · DOI · Paper page
- AG Paulovich, DP Toczyski, LH Hartwell, When checkpoints fail. Cell 88, 315–321 (1997). · DOI · Paper page
- N Walworth, S Davey, D Beach, Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363, 368–371 (1993). · DOI · Paper page
- H Takai, et al., Aberrant cell cycle checkpoint function and early embryonic death in Chk1(−/−) mice. Genes Dev 14, 1439–1447 (2000). · DOI · Paper page
- J Bartek, J Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421–429 (2003). · DOI · Paper page
- NC Walworth, Cell-cycle checkpoint kinases: Checking in on the cell cycle. Curr Opin Cell Biol 12, 697–704 (2000). · DOI
- G Zachos, DA Gillespie, Exercising restraints: Role of Chk1 in regulating the onset and progression of unperturbed mitosis in vertebrate cells. Cell Cycle 6, 810–813 (2007). · DOI
- K Zaugg, et al., Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci USA 104, 3805–3810 (2007). · DOI
- MJ O'Connell, JM Raleigh, HM Verkade, P Nurse, Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 16, 545–554 (1997). · DOI · Paper page
- J Lee, A Kumagai, WG Dunphy, Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 12, 551–563 (2001). · DOI · Paper page
- A Lopez-Girona, B Furnari, O Mondesert, P Russell, Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397, 172–175 (1999). · DOI · Paper page
- C Feijoo, et al., Activation of mammalian Chk1 during DNA replication arrest: A role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol 154, 913–923 (2001). · DOI · Paper page
- CS Sørensen, et al., Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247–258 (2003). · DOI · Paper page
- E Petermann, et al., Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol 26, 3319–3326 (2006). · DOI · Paper page
- G Zachos, et al., Chk1 is required for spindle checkpoint function. Dev Cell 12, 247–260 (2007). · DOI · Paper page
- J Tang, RL Erikson, X Liu, Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1). Proc Natl Acad Sci USA 103, 11964–11969 (2006). · DOI · Paper page
- D Wilsker, E Petermann, T Helleday, F Bunz, Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc Natl Acad Sci USA 105, 20752–20757 (2008). · DOI · Paper page
- Y Katsuragi, N Sagata, Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation. Mol Biol Cell 15, 1680–1689 (2004). · DOI · Paper page
- M Walker, EJ Black, V Oehler, DA Gillespie, MT Scott, Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene 28, 2314–2323 (2009). · DOI · Paper page
- C Tapia-Alveal, TM Calonge, MJ O'Connell, Regulation of Chk1. Cell Div 4, 8 (2009). · DOI
- P Chen, et al., The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1: Implications for Chk1 regulation. Cell 100, 681–692 (2000). · DOI · Paper page
- A Krämer, J Lukas, J Bartek, Checking out the centrosome. Cell Cycle 3, 1390–1393 (2004). · DOI
- A Krämer, et al., Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol 6, 884–891 (2004). · DOI · Paper page
- MH Lam, Q Liu, SJ Elledge, JM Rosen, Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6, 45–59 (2004). · DOI · Paper page
- T Fishler, et al., Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene 29, 4007–4017 (2010). · DOI · Paper page
- H Capasso, et al., Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest. J Cell Sci 115, 4555–4564 (2002). · DOI · Paper page
- C Latif, NR den Elzen, MJ O'Connell, DNA damage checkpoint maintenance through sustained Chk1 activity. J Cell Sci 117, 3489–3498 (2004). · DOI
- Y Dai, S Grant, New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 16, 376–383 (2010). · DOI · Paper page
- C Merry, K Fu, J Wang, IJ Yeh, Y Zhang, Targeting the checkpoint kinase Chk1 in cancer therapy. Cell Cycle 9, 279–283 (2010). · DOI
- CX Ma, JW Janetka, H Piwnica-Worms, Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med 17, 88–96 (2011). · DOI · Paper page
Cited by
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Roles of Chk1 in cell biology and cancer therapy
Zhang, Y., & Hunter, T. (2014) · International Journal of Cancer · doi:10.1002/ijc.28226 · Cited by 462
Checkpoint kinase 1 in DNA damage response and cell cycle regulation
Patil, M., Pabla, N., & Dong, Z. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1307-3 · Cited by 317
“Our latest work has identified a splice variant of Chk1, which may act as an endogenous repressor of Chk1 [80].”
Self-citationNeuronal synapse formation induced by microglia and interleukin 10
Lim, S.-H., Park, E., You, B., Jung, Y., Park, A.-R., Park, S. G., & Lee, J.-R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081218 · Cited by 224
Calcium signaling and gliotransmission in normal vs. reactive astrocytes
Agulhon, C., Sun, M.-Y., Murphy, T., Myers, T., Lauderdale, K., & Fiacco, T. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00139 · Cited by 167
Metadata
- Authors
- Pabla, N., Bhatt, K., & Dong, Z.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-12-19
- Volume
- 109
- Issue
- 1
- Pages
- 197-202
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2134487183
- Cited by
- 66
- References
- 13
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.